Fig 1.

Six-year probability of major molecular response (MMR), 4-log reduction in transcript levels, and complete molecular response (CMR) in the 87 enrolled patients according to the measured adherence rate. The probability of MMR for the 23 patients with an adherence rate ≤ 90% was 13.9%, whereas the probability was 93.7% for the 64 patients with an adherence rate greater than 90% (P < .001). Similarly, the probability of a 4-log reduction was 4.3% versus 76% (P < .001), and the probability of CMR was 0% versus 43.8% (P = .002).